Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,266 | -5,014 | -2,821 | -7,502 | -6,329 |
| Depreciation Amortization | 800 | 521 | 274 | 1,303 | 979 |
| Accounts receivable | -42 | -98 | -41 | N/A | N/A |
| Accounts payable and accrued liabilities | 174 | 85 | 103 | -326 | -202 |
| Other Working Capital | 366 | 20 | -105 | 29 | -225 |
| Other Operating Activity | -2,213 | -815 | -403 | -884 | 499 |
| Operating Cash Flow | $-7,181 | $-5,301 | $-2,993 | $-7,380 | $-5,278 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | -3 | -3 | -160 | -160 |
| Sale Of Investment | 1,699 | 1,500 | 500 | 3,370 | 3,371 |
| Purchase Sale Intangibles | -36 | -14 | -11 | -294 | -282 |
| Other Investing Activity | -36 | -14 | -11 | -294 | -268 |
| Investing Cash Flow | $1,643 | $1,483 | $486 | $2,916 | $2,943 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,543 | 606 | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | N/A | -1 | -1 |
| Common Stock Issued | 2,180 | 2,115 | 875 | 4,744 | 4,694 |
| Other Financing Activity | -90 | -89 | 0 | 14 | 0 |
| Financing Cash Flow | $3,633 | $2,632 | $875 | $4,757 | $4,693 |
| Beginning Cash Position | 2,408 | 2,408 | 2,408 | 2,115 | 2,115 |
| End Cash Position | 503 | 1,222 | 776 | 2,408 | 4,473 |
| Net Cash Flow | $-1,905 | $-1,186 | $-1,632 | $293 | $2,358 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,181 | -5,301 | -2,993 | -7,380 | -5,278 |
| Capital Expenditure | -20 | -3 | -3 | -160 | -160 |
| Free Cash Flow | -7,201 | -5,304 | -2,996 | -7,540 | -5,438 |